RE: MHRA22 Apr 2021 11:35
some people are so opposed to seeing potential bad news that it just goes straight over their head.
The Mologic test is not on a list of tests, published yesterday by uk gov, that have passed phase3a validation. Development and scale up of that test was finished in Decemeber, and it was CE-ed by mologic. It was trialled before that at Heathrow and other places. So the final version of the test has been available for 4 months to be evaluated by Porton down.
ODX shareholders are under the assumption that any day now, the mologic test will be picked by the same uk gov to make 2M a week. That list now makes that selection look increasingly unlikely.
ODX have spent months TT that test (not complete). If they have to start TTing another test, then given ODXs history of TT, it'll be Jul or Aug before a single antigen LFT test is delivered to uk gov. And good luck in selling the visitect rebrand commercially, why would someone buy it when there are around 20 others that have passed portdon down evaluation ?